KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Inventory (2017 - 2025)

Historic Inventory for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $614.5 million.

  • Amneal Pharmaceuticals' Inventory rose 304.2% to $614.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $614.5 million, marking a year-over-year increase of 304.2%. This contributed to the annual value of $612.5 million for FY2024, which is 534.41% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Inventory stood at $614.5 million for Q3 2025, which was up 304.2% from $609.0 million recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Inventory high stood at $614.5 million for Q3 2025, and its period low was $489.4 million during Q4 2021.
  • For the 5-year period, Amneal Pharmaceuticals' Inventory averaged around $556.2 million, with its median value being $550.6 million (2023).
  • Data for Amneal Pharmaceuticals' Inventory shows a peak YoY increase of 1789.12% (in 2021) and a maximum YoY decrease of 25.68% (in 2021) over the last 5 years.
  • Over the past 5 years, Amneal Pharmaceuticals' Inventory (Quarter) stood at $489.4 million in 2021, then rose by 8.45% to $530.7 million in 2022, then grew by 9.54% to $581.4 million in 2023, then rose by 5.34% to $612.5 million in 2024, then rose by 0.33% to $614.5 million in 2025.
  • Its Inventory stands at $614.5 million for Q3 2025, versus $609.0 million for Q2 2025 and $601.4 million for Q1 2025.